Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2

Nov 20, 2024

Cyborg cardiac patch offers alternative to heart transplants

Posted by in categories: biotech/medical, cyborgs

bigsmile yay face_with_colon_three


An engineered cardiac patch has been created that incorporates human cells with flexible electronics and a nanocomposite structure to not only replace damaged heart tissue, but also provide remote monitoring, electrical stimulation, and the release of medication on demand. Using electroactive polymers and a combination of biological and engineered parts, the patch contracts and expands just like normal human heart tissue, but regulates those actions with the precision of a finely-tuned machine.

Invented by Professor Tal Dvir and PhD student Ron Feiner of Tel Aviv University (TAU), this new breakthrough medical device is claimed by its creators to have capabilities that surpass those of human tissue alone. As such, this patch may give new hope to people such as those 25 percent on the US national waiting list that may die before a suitable transplant heart becomes available, by effectively offering a way to fix – rather than replace – their own heart.

Continue reading “Cyborg cardiac patch offers alternative to heart transplants” »

Nov 20, 2024

Elon Musk said his AI-brain-chips company could ‘solve’ autism and schizophrenia

Posted by in categories: biotech/medical, Elon Musk, robotics/AI

Musk said he thinks Neuralink will “solve a lot of brain-related diseases,” naming autism and schizophrenia as examples. Autism is not a disease.

Nov 20, 2024

Can We Harness the Body’s Electrical Currents?

Posted by in categories: biotech/medical, life extension

Scientists say bioelectricity is the body’s master control. A few aim to use it to regrow limbs, treat cancer — even unlock immortality.

Nov 20, 2024

Local actuation of organoids by magnetic nanoparticles

Posted by in categories: biotech/medical, genetics, nanotechnology, neuroscience

Tissues take shape during development through a series of morphogenetic movements guided by local cell-scale forces. While current in vitro approaches subjecting tissues to homogenous stresses, it is currently no possible to recapitulate highly local spatially varying forces. Here we develop a method for local actuation of organoids using embedded magnetic nanoparticles. Sequential aggregation of magnetically labelled human pluripotent stem cells followed by actuation by a magnetic field produces localized magnetic clusters within the organoid. These clusters impose local mechanical forces on the surrounding tissue in response to applied global magnetic fields. We show that precise, spatially defined actuation provides short-term mechanical tissue perturbations as well as long-term cytoskeleton remodeling. We demonstrate that local magnetically-driven actuation guides asymmetric growth and proliferation, leading to enhanced patterning in human neural organoids. We show that this approach is applicable to other model systems by observing polarized patterning in paraxial mesoderm organoids upon local magnetic actuation. This versatile approach allows for local, controllable mechanical actuation in multicellular constructs, and is widely applicable to interrogate the role of local mechanotransduction in developmental and disease model systems.

The authors have declared no competing interest.

Nov 20, 2024

Which Medtech Products Made Time Magazine’s Best Inventions of 2024 List?

Posted by in categories: biotech/medical, robotics/AI, wearables

The industry showed out in spades for this year’s list, highlighting devices in medical AI, surgical robotics, wearables, and femtech, among others.

Nov 20, 2024

Scientists use DNA from 422-million-year-old cells to create a mouse

Posted by in categories: biotech/medical, evolution, genetics, life extension

Choanoflagellates, animals’ closest relatives, have pluripotency genes, reshaping views on their evolution.


The research highlights how evolution repurposes existing genetic tools, turning them into versatile drivers of innovation. This adaptability underscores how foundational processes in unicellular organisms laid the groundwork for the development of complex life forms.

Continue reading “Scientists use DNA from 422-million-year-old cells to create a mouse” »

Nov 20, 2024

Scientists discover a new giant virus that infects freshwater algae

Posted by in category: biotech/medical

Scientists from the Biology Centre of the Czech Academy of Sciences found forty new freshwater viruses infecting aquatic microorganisms this year. The first one, which they isolated and described in detail, was named Budvirus after the South Bohemian capital České Budějovice. It belongs to “Giant Viruses” and it infects unicellular algae called cryptophytes.

Researchers have confirmed that this virus has an important role in the ecosystem, as it controls algal bloom, helping to maintain balance in the aquatic environment. The discoveries of all the viruses were made at the Římov reservoir near České Budějovice, which has been regularly monitored by South Bohemian hydrobiologists for five decades and is one of the most studied freshwater reservoirs in Europe. The work is published in The ISME Journal.

Although we have freshwater ecosystems such as lakes, ponds, reservoirs and rivers all around us, their microscopic representatives, especially viruses and bacteria, are still a little-explored area. A drop of water can contain a million bacteria and ten times more viruses, but only a handful of them have been described. Recent methods, such as environmental DNA analysis, are making great strides in the study of the aquatic microworld. This is also one of the methods used by the Czech scientific team.

Nov 20, 2024

Scientists glue two proteins together, driving cancer cells to self-destruct

Posted by in categories: biotech/medical, materials

Our bodies divest themselves of 60 billion cells every day through a natural process of cell culling and turnover called apoptosis.

These cells — mainly blood and gut cells — are all replaced with new ones, but the way our bodies rid themselves of material could have profound implications for cancer therapies in a new approach developed by Stanford Medicine researchers.

They aim to use this natural method of cell death to trick cancer cells into disposing of themselves. Their method accomplishes this by artificially bringing together two proteins in such a way that the new compound switches on a set of cell death genes, ultimately driving tumor cells to turn on themselves. The researchers describe their latest such compound in a paper published Oct. 4 in Science.

Nov 20, 2024

Brain Cells Boost Damage Caused by Alzheimer’s Risk Variant

Posted by in categories: biotech/medical, neuroscience

Sometimes there are slightly different versions, or sequences of genes. There are several versions of the apolipoprotein E (APOE) gene, for example. One of them, called APOE4, has been linked to a much higher risk of developing Alzheimer’s disease, and carriers often have worse forms of the disease compared to carriers of other forms like APOE3. There are immune cells in the brain called microglia that help protect the brain from damage and harm. But when APOE4 is expressed, microglia seem to start to cause inflammation, and misfolded proteins to form in the brain, which can lead to serious problems. The findings have been reported in Cell Stem Cell.

In this work, the researchers developed a mouse model that could generate the human APOE4 protein in their brains. Next, the investigators eliminated microglia from these mouse brains. The formation of two misfolded proteins that are hallmarks of Alzheimer’s diseases: amyloid and tau, was halted.

Nov 20, 2024

A Genetic Deficiency That Raises Susceptibility to Many Types of Flu

Posted by in categories: biotech/medical, genetics

There are many processes and proteins that help the body fight a flu infection. One of them is known as IFITM3. Researchers have now shown that this protein can help prevent viruses from mutating after they have infected a new host. But some people are deficient in IFITM3, which can raise their risk of a severe flu infection. That deficiency is not unusual in some groups. For example, around twenty percent of Chinese people and four percent of people with European ancestry carry variants in IFITM3 that can interfere with the protein’s expression. This study has shown that these genetic variants can allow flu viruses to establish infections even when the virus is present at very low levels that would not usually cause infection. The findings have been reported in Nature Communications.

The IFITM3 (interferon-induced transmembrane protein 3) protein is part of the innate immune system, and is generated at high levels after the detection of a flu infection. It can sequester viral particles so that they are not able to replicate, which reduces the severity of flu infections. Mouse models that are IFITM3 deficient are extremely vulnerable to the flu.

Page 2 of 2,74712345678Last